Investigator Studies Program (MISP): Hepatitis A, Hepatitis B
Effective January 2019, the Investigator Studies Program (MISP) Committee will accept proposals within our current areas of interest (AOI) up to April 5, 2019. This is a competitive process that will be conducted by the MISP in 2019. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below.
The following areas are of interest to Investigator Studies Program Committee:
- Studies evaluating the epidemiology and health economic burden of hepatitis A in regions, countries or populations in which these data are limited.
- Studies evaluating the mechanisms underlying non-response to hepatitis B vaccination, as well as strategies to overcome non-response.
- Studies that assess novel methods for improving series completion in high risk populations.
Please complete a full protocol and detailed budget via Visiontracker
, our company's on-line study management system (in US) or your MSD country representative (outside US). The proposals will be collectively reviewed and selected by the MISP Committee.
Critical Activities and Timelines:
|Full Protocol Submission with Detailed Budget
||April 5, 2019
|Final Comments to Investigator
||June 14, 2019
This site is intended for US investigators only. Investigators outside of the US interested in submitting research proposals to the Investigator
Studies Program should contact their local MSD office